Repository logo
 

Indian Journal of Research in Homoeopathy

Permanent URI for this collectionhttps://aoh.ccrhlibrary.in/handle/123456789/38

Browse

Author: search.filters.author.Bhuvaneswari, RSubject: search.filters.subject.Homoeopathy

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Individualised homoeopathic treatment of paranoid schizophrenia with potentised Phosphorus
    (Central Council for Research in Homoeopathy, 2025) Bhuvaneswari, R; Sakthivel, Vaiyapuri
    Background: Paranoid schizophrenia is a severe mental disorder that affects approximately one percent of the world population, with devastating consequences for affected individuals and their families. Homoeopathy could be an effective alternative mode of treatment and can minimise the consequences of it. This case report aimed to highlight the significance of using only individualised homoeopathic medicines in the treatment of paranoid schizophrenia without conventional medicine. Case Summary: A 30-year-old male complained of someone controlling his mind, someone talking about him. He was suspicious of the food he was served, talked and laughed to himself and slept insufficiently. The case was diagnosed as paranoid schizophrenia by the psychiatrist. The severity of the disease was measured by the Positive and Negative Syndrome Scale (PANSS) and assessment of the positive symptoms was done by Scale for the Assessment of Positive Symptoms (SAPS); the symptoms were recorded at the baseline and every month for the duration of 17 months, with the help of the psychiatrist. Phosphorus 30C was prescribed on the basis of individualisation. No homoeopathic aggravation was reported during the treatment. PANSS score of 84 at baseline reduced to 32 and SAPS score of 56 reduced to zero, within ten months of treatment and remained so for up to 17 months, including the period of observation. MONARCH score of +8 indicated a causal attribution of homoeopathic treatment to disease improvement.
  • Thumbnail Image
    Item
    A pragmatic, open-label study to evaluate the response of homoeopathic treatment in vitiligo
    (Central Council for Research in Homoeopathy, 2024) Taneja, D; Mittal, R; Bhuvaneswari, R
    Background: Homoeopathy is commonly used by patients suffering from vitiligo. The treatment response needs to be assessed on standardised scales in pragmatic settings. Objective: The study aimed to evaluate response to homoeopathic treatment in vitiligo severity and quality of life using the vitiligo area scoring index (VASI) score, Vitiligo European Task Force (VETF) score and dermatological life quality index (DLQI) score. Materials and Methods: This study was undertaken in dermatology outpatient departments at 11 research institutes of the Central Council for Research in Homoeopathy. Participants, in the age group 18–60 years, any gender, presenting with at least one vitiligo skin patch above the size of 2 cm × 2 cm were included and invited to participate in the study and were regularly followed up over a period of one year. Participants completing one-year follow-up were included in a long-term assessment for another two years. Results: A total of 361 participants were enrolled, 266 completed one-year treatment; 139 continued treatment for additional twelve months, and 62 participants completed three years. Change in VASI and VETF area scores was not significant over one year. Post hoc test identified change in score for the VETF stage as significant at 6 months (p = 0.013), 9 months (p = 0.000), and 12 months (p = 0.000) from baseline. The spread score reduced significantly from baseline (p = 0.000), as also the change in mean scores of DLQI (p = 0.000), patient (p = 0.000) and physician global assessments (p = 0.000). Conclusion: The extent of depigmentation in vitiligo (staging) and spread decreased significantly along with improvement in quality of life with regular homoeopathic treatment.